Company can't care. Really why would they and why would we . 90% of bio stocks under development sell shares to pay for research. So they basically diluted share count and lower pps every time they need money. Getting me hot, and I have a really small stake here. Not even worth the stress. But it's sickening watching anyone lose money. I bet some here lost more then they could afford.
News 
Market Data 
Discover 
